The power of national collaboration
Waiting in the shadow of a no deal Brexit
Life Sciences sector responds to report on the impact of Brexit
Life Sciences Industrial Strategy paves way to support UK bioscience growth
BIA report shows UK is on track to build the world’s third global biotech cluster
BIA explore options for working with EU post-Brexit
Proposals by NICE and NHS England could slow down or stop access to new innovative medicines for patients with rare diseases
BIA statement regarding the Prime Minister's speech on Brexit
13th Annual bioProcessUK Conference
UK biotech venture capital hit record high in 2015 with £489m raised, finds report
BIA launches briefing paper on orphan medicinal products
UK CEO and Investor Forum
NHS England publishes authoritative information on biosimilar medicines
